Proposal to widen access to empagliflozin for use in the treatment of chronic heart failure (HFrEF)
By thomas
13 September 2024
13 September 2024
- About us
- Members1
- Audit tools
- Business tools
- ICPSA tools
- Member advice lines
- Member discounts
- Newsletters
- Online clinical resources
- Patient counselling resources
- Pharmacy practice resources
- Pharmacy services
- Posters, signs, and marketing resources
- Quality improvement tools
- Sector advocacy
- Workplace requirements
- Join1